SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank100
3Y CAGR+45.4%
5Y CAGR+22.4%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
+45.4%/yr
vs +6.6%/yr prior
5Y CAGR
+22.4%/yr
Recent acceleration
Acceleration
+38.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$137.37B+24.3%
2024$110.49B+18.0%
2023$93.61B+109.7%
2022$44.65B+60.2%
2021$27.87B-44.2%
2020$49.95B+31.1%
2019$38.09B+10.3%
2018$34.54B-61.9%
2017$90.58B+37.8%
2016$65.72B-